Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 7/20 | 0.62 |
| ▸ | CES2 | O00748 | 6/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3009970 | 0.93 | CES2 (0.64) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL3188212 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL3187591 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL16007022 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL15708761 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL7640351 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL53567 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL1088229 | 0.91 | CES2 (0.65) | CES1CES2FAAHALDH1A1HDAC11 | |
| SCHEMBL992042 | 0.84 | — | — | |
| SCHEMBL7614127 | 0.83 | HAO1 (0.58) | CES1CES2FAAHALDH1A1HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004771-A | Method for producing organic sulfinate compound | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-118496783-A | UV (ultraviolet) viscosity reducing adhesive as well as preparation method and application thereof | 南京大学 | 2024-08-16 | — | — | CN | claimed |
| US-9487602-B2 | Furan based resin, process for the preparation thereof, and use of the compound | DSM IP ASSETS B.V. (NL) | 2016-11-08 | — | — | US | claimed |
| US-20130109822-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2013-05-02 | — | — | US | claimed |
| US-20110306735-A1 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2011-12-15 | — | — | US | claimed |
| US-20110021740-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2011-01-27 | — | — | US | claimed |
| EP-2222656-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP Assets B.V. (NL) | 2010-09-01 | — | — | EP | claimed |
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | DSM IP ASSETS B.V. (NL) | 2009-08-13 | — | — | US | claimed |
| WO-2009077587-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2009-06-25 | — | — | WO | claimed |
| EP-2024317-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSMIP Assets B.V. (NL) | 2009-02-18 | — | — | EP | claimed |
| WO-2007140941-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2007-12-13 | — | — | WO | claimed |
| CN-120078134-A | Application of phytic acid in reducing bad flavor of aquatic products and method for reducing bad flavor of aquatic products | 大连大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-120004771-A | Method for producing organic sulfinate compound | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-118496783-A | UV (ultraviolet) viscosity reducing adhesive as well as preparation method and application thereof | 南京大学 | 2024-08-16 | — | — | CN | disclosed |
| EP-4329743-A1 | PYRUVATE ESTERS FOR THE TREATMENT OF VIRAL DISEASES | Birkenmeier, Gerd (DE) | 2024-03-06 | — | — | EP | disclosed |
| US-3969380-A | 16-Fluoro prostaglandin F2 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969379-A | 13,14-Dihydro-16-fluoro prostaglandin A1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969381-A | 13,14-Dihydro-16-fluoro prostaglandin B1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969377-A | 16-Fluoro prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3962293-A | 13,14-Dihydro-16-fluoro prostaglandin F1 | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | HRH3, HRH1, C9 | CES1 2109/4885CES2 973/4885CA1 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.